Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 1—January 2026

Research Letter

Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024

Justin Charles-Antoine DestoopComments to Author , Corentin Poignon, William Danjou, Alexandre Bleibtreu, Valerie Pourcher, and Gentiane Monsel
Author affiliation: Pitié-Salpêtrière University Hospital, Paris, France (J.C.-A. Destoop, W. Danjou, A. Bleibtreu, V. Pourcher, G. Monsel); Dermatological Infectiology and Sexually Transmitted Infections Group of the French Society of Dermatology, Paris (J.C.-A. Destoop, G. Monsel); Sorbonne Université, Paris (C. Poignon); French National Institute of Health and Medical Research, Paris (C. Poignon, A. Bleibtreu, V. Pourcher)

Main Article

Table

Susceptibility of clinical isolates studied in prior reports and in our investigation of Mycobacterium decipiens infection in patient treated with anti–tumor necrosis factor-α therapy, France, 2024*

Antimicrobial drug
 MIC of clinical isolates, μg/mL

*The S/I/R breakpoints have been defined by analogy with the Clinical and Laboratory Standards Institute breakpoints for slowly growing mycobacteria other than M. avium and M. kansasii (5). I, intermediate; R, resistant; S, susceptible.

Main Article

References
  1. Simner  PJ, Hyle  EP, Buckwalter  SP, Branda  JA, Brown-Elliott  BA, Franklin  J, et al. Tenosynovitis caused by a novel nontuberculous Mycobacterium species initially misidentified as a member of the Mycobacterium tuberculosis complex. J Clin Microbiol. 2014;52:4414–8.
  2. Brown-Elliott  BA, Simmer  PJ, Trovato  A, Hyle  EP, Droz  S, Buckwalter  SP, et al. Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex. Int J Syst Evol Microbiol. 2018;68:3557–62.
  3. Richter  E, Rüsch-Gerdes  S, Hillemann  D. Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. J Clin Microbiol. 2006;44:1769–75. DOIPubMedGoogle Scholar
  4. Hall  MB. Mycobacterium representative Kraken2 database. Zenodo. 2023 [cited 2025 Aug 19]. https://zenodo.org/doi/10.5281/zenodo.8339821
  5. Clinical and Laboratory Standards Institute. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 2nd edition. CLSI supplement M24S. Wayne (PA): The Institute; 2023.
  6. Sous  C, Frigui  W, Pawlik  A, Sayes  F, Ma  L, Cokelaer  T, et al. Genomic and phenotypic characterization of Mycobacterium tuberculosis’ closest-related non-tuberculous mycobacteria. Microbiol Spectr. 2024;12:e0412623.

Main Article

Page created: December 24, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external